The addition of adjuvant nivolumab to standard-of-care radiotherapy and cisplatin improved survival for patients with locally ...

Full House’s Dave Coulier shared how he’s been adjusting to the side effects of chemotherapy treatment amid his battle with stage 3 Non-Hodgkin’s lymphoma.

In blood cancers such as chronic lymphocytic leukemia, B cells of the immune system multiply uncontrollably. One form of ...

Post-operative nivolumab significantly improved disease-free survival in resected locally advanced head and neck cancer, ...

A 68-year-old cancer survivor has become the first to conquer remote Pakistan peak alongside his 74-year-old climbing partner despite undergoing life-altering surgery that left him living with a ...

Two months after welcoming their daughter Paloma, Jett Puckett revealed that his wife Campbell “Pookie” Puckett underwent ...

Christine Kannler describes what firefighters need to be on the look out for when it comes to signs of skin cancer.

The Food and Drug Administration has approved Unloxcyt (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma.

GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC ...

The following is a summary of “Impact of preceding treatment for head and neck squamous cell carcinoma on synchronous ...

Medical advancements make early-detected cancers more manageable and treatable, with immunotherapy and CAR T cell therapy ...

Cemiplimab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Penile Cancer.